Owkin: Funding, Investors & Team (Sep 2026)
Owkin is a French-American startup that specializes in AI and federated learning for medical research. It was co-founded in 2016 by Dr Thomas Clozel M.D., a clinical research doctor and former assistant professor in clinical hematology, and Dr Gilles Wainrib, Ph.D., a pioneer in the field of artificial intelligence in biology. Owkin has recently published groundbreaking research at the frontier of AI and medicine in Nature Medicine, Nature Communications and Hepatology. The Owkin Platform connects life science companies with world-class academic researchers and hospitals to share deep medical insights for drug discovery and development. Using federated learning and breakthrough collaborative AI technology, Owkin enables its partners to unlock siloed datasets while protecting patient privacy and securing proprietary data. Through sharing high-value insights, the company powers unprecedented collaboration to improve patient outcomes. Owkin has raised $255M investment from life science companies and prominent VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Key achievements to date include HealthChain and MELLODDY; two Owkin led federated learning consortia fueling unprecedented collaboration in academic research and drug discovery, respectively.
Owkin has raised $248M across 3 funding rounds on record, the most recent a Series B of $50.0M announced in Jun 2022.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Owkin Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Owkin Funding Rounds
Owkin raised $18.0M in an undisclosed round announced in Jul 2020.
1.3 years later, a Corporate Round of $180M was announced in Nov 2021.
7 months later, a Series B of $50.0M was announced in Jun 2022.
Owkin Founders and Leadership Team
Contact details for the Owkin team: 2 of 2 have an email address on file.
Start 14-day free trial →Owkin Funding Compared to Other Artificial Intelligence Startups
Owkin's latest round of $50.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Owkin in Artificial Intelligence and New York
Companies Similar to Owkin
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Owkin Funding FAQs
What does Owkin do?
Owkin is a French-American startup that specializes in AI and federated learning for medical research. It was co-founded in 2016 by Dr Thomas Clozel M.D., a clinical research doctor and former assistant professor in clinical hematology, and Dr Gilles Wainrib, Ph.D., a pioneer in the field of artificial intelligence in biology. Owkin has recently published groundbreaking research at the frontier of AI and medicine in Nature Medicine, Nature Communications and Hepatology. The Owkin Platform connects life science companies with world-class academic researchers and hospitals to share deep medical insights for drug discovery and development. Using federated learning and breakthrough collaborative AI technology, Owkin enables its partners to unlock siloed datasets while protecting patient privacy and securing proprietary data. Through sharing high-value insights, the company powers unprecedented collaboration to improve patient outcomes. Owkin has raised $255M investment from life science companies and prominent VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Key achievements to date include HealthChain and MELLODDY; two Owkin led federated learning consortia fueling unprecedented collaboration in academic research and drug discovery, respectively.
How much funding has Owkin raised?
Owkin has raised $248M across 3 rounds on record. The most recent is a Series B of $50.0M announced in Jun 2022.
When did Owkin last raise funding?
Owkin's most recent funding round on record is a Series B of $50.0M, announced in Jun 2022.
Who founded Owkin?
FundedIQ lists Gilles Wainrib (Founder) at Owkin.
Who is the CEO of Owkin?
Thomas Clozel is listed as CEO at Owkin.
Where is Owkin headquartered?
Owkin is based in New York, United States.
How many employees does Owkin have?
Owkin is in the 101-250 employee band.
How does Owkin's funding compare to other Artificial Intelligence startups?
Owkin's latest round of $50.0M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Owkin Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Owkin is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.